Search

Brian N. Vinson

Examiner (ID: 1815, Phone: (571)272-2614 , Office: P/2913 )

Most Active Art Unit
2911
Art Unit(s)
2911, 2913, 2900, 2901
Total Applications
12036
Issued Applications
11911
Pending Applications
2
Abandoned Applications
123

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18270229 [patent_doc_number] => 20230091471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/673703 [patent_app_country] => US [patent_app_date] => 2022-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62161 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673703 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/673703
CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS Feb 15, 2022 Abandoned
Array ( [id] => 18202402 [patent_doc_number] => 11584784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-21 [patent_title] => Systems and methods for manufacturing a silk fibroin solution and powders containing silk fibroin [patent_app_type] => utility [patent_app_number] => 17/650570 [patent_app_country] => US [patent_app_date] => 2022-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 23 [patent_no_of_words] => 21764 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650570 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/650570
Systems and methods for manufacturing a silk fibroin solution and powders containing silk fibroin Feb 9, 2022 Issued
Array ( [id] => 17627274 [patent_doc_number] => 20220162289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME [patent_app_type] => utility [patent_app_number] => 17/667330 [patent_app_country] => US [patent_app_date] => 2022-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67611 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667330 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/667330
Anti-VEGF protein compositions and methods for producing the same Feb 7, 2022 Issued
Array ( [id] => 17805990 [patent_doc_number] => 20220257825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => USE OF SELF-ASSEMBLING POLYPEPTIDES AS TISSUE ADHESIVES [patent_app_type] => utility [patent_app_number] => 17/665947 [patent_app_country] => US [patent_app_date] => 2022-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32873 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665947 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/665947
Use of self-assembling polypeptides as tissue adhesives Feb 6, 2022 Issued
Array ( [id] => 17655510 [patent_doc_number] => 20220175975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => HER3 Peptides for Imaging and Radiotherapy [patent_app_type] => utility [patent_app_number] => 17/562861 [patent_app_country] => US [patent_app_date] => 2021-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15590 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17562861 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/562861
HER3 peptides for imaging and radiotherapy Dec 26, 2021 Issued
Array ( [id] => 17655415 [patent_doc_number] => 20220175880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => CHLORIDE SALT OF TAT-NR2B9C [patent_app_type] => utility [patent_app_number] => 17/545995 [patent_app_country] => US [patent_app_date] => 2021-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17806 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17545995 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/545995
Chloride salt of TAT-NR2B9C Dec 7, 2021 Issued
Array ( [id] => 17790386 [patent_doc_number] => 20220249477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING VIRAL OR VIRALLY-INDUCED CONDITIONS [patent_app_type] => utility [patent_app_number] => 17/545217 [patent_app_country] => US [patent_app_date] => 2021-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32580 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17545217 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/545217
Methods and compositions for treating viral or virally-induced conditions Dec 7, 2021 Issued
Array ( [id] => 17480712 [patent_doc_number] => 20220088216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS [patent_app_type] => utility [patent_app_number] => 17/540549 [patent_app_country] => US [patent_app_date] => 2021-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15082 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17540549 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/540549
Virus-like particle conjugates for diagnosis and treatment of tumors Dec 1, 2021 Issued
Array ( [id] => 17702837 [patent_doc_number] => 20220202843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => METHODS OF TREATMENT FOR BACTERIAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/541019 [patent_app_country] => US [patent_app_date] => 2021-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13926 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17541019 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/541019
METHODS OF TREATMENT FOR BACTERIAL INFECTIONS Dec 1, 2021 Abandoned
Array ( [id] => 18777857 [patent_doc_number] => 11819533 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-21 [patent_title] => Compositions and methods for the treatment of fungal infections [patent_app_type] => utility [patent_app_number] => 17/539727 [patent_app_country] => US [patent_app_date] => 2021-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 27 [patent_no_of_words] => 12283 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17539727 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/539727
Compositions and methods for the treatment of fungal infections Nov 30, 2021 Issued
Array ( [id] => 17881205 [patent_doc_number] => 20220296682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => CNP PRODRUGS WITH LARGE CARRIER MOIETIES [patent_app_type] => utility [patent_app_number] => 17/526481 [patent_app_country] => US [patent_app_date] => 2021-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53725 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17526481 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/526481
CNP PRODRUGS WITH LARGE CARRIER MOIETIES Nov 14, 2021 Abandoned
Array ( [id] => 17720434 [patent_doc_number] => 20220213154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => AGENTS MODULATING BETA-CATENIN FUNCTIONS AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 17/518247 [patent_app_country] => US [patent_app_date] => 2021-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54560 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17518247 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/518247
Agents modulating beta-catenin functions and methods thereof Nov 2, 2021 Issued
Array ( [id] => 17850552 [patent_doc_number] => 20220280593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE [patent_app_type] => utility [patent_app_number] => 17/514469 [patent_app_country] => US [patent_app_date] => 2021-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21722 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17514469 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/514469
METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE Oct 28, 2021 Abandoned
Array ( [id] => 17905529 [patent_doc_number] => 11459373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-04 [patent_title] => Anti-VEGF protein compositions and methods for producing the same [patent_app_type] => utility [patent_app_number] => 17/500735 [patent_app_country] => US [patent_app_date] => 2021-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 86 [patent_no_of_words] => 67535 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500735 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/500735
Anti-VEGF protein compositions and methods for producing the same Oct 12, 2021 Issued
Array ( [id] => 17505137 [patent_doc_number] => 20220098239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES [patent_app_type] => utility [patent_app_number] => 17/499859 [patent_app_country] => US [patent_app_date] => 2021-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16225 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499859 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/499859
Inhibition of pulmonary fibrosis with nutlin-3A and peptides Oct 11, 2021 Issued
Array ( [id] => 18374422 [patent_doc_number] => 20230149501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => METHODS FOR REDUCING OXIDATIVE DAMAGE [patent_app_type] => utility [patent_app_number] => 17/493551 [patent_app_country] => US [patent_app_date] => 2021-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16546 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493551 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/493551
METHODS FOR REDUCING OXIDATIVE DAMAGE Oct 3, 2021 Abandoned
Array ( [id] => 17343668 [patent_doc_number] => 20220009999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME [patent_app_type] => utility [patent_app_number] => 17/489495 [patent_app_country] => US [patent_app_date] => 2021-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67717 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17489495 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/489495
Anti-VEGF protein compositions and methods for producing the same Sep 28, 2021 Issued
Array ( [id] => 19423769 [patent_doc_number] => 12083160 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-10 [patent_title] => Polypeptides binding to human complement C5 [patent_app_type] => utility [patent_app_number] => 17/479101 [patent_app_country] => US [patent_app_date] => 2021-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 23177 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479101 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/479101
Polypeptides binding to human complement C5 Sep 19, 2021 Issued
Array ( [id] => 17314460 [patent_doc_number] => 20210403508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME [patent_app_type] => utility [patent_app_number] => 17/478027 [patent_app_country] => US [patent_app_date] => 2021-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32312 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17478027 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/478027
Ultra-pure agonists of guanylate cyclase C, method of making and using same Sep 16, 2021 Issued
Array ( [id] => 17342209 [patent_doc_number] => 20220008540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => METHODS OF TREATING OR PREVENTING STENT THROMBOSIS [patent_app_type] => utility [patent_app_number] => 17/474114 [patent_app_country] => US [patent_app_date] => 2021-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21427 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474114 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/474114
METHODS OF TREATING OR PREVENTING STENT THROMBOSIS Sep 13, 2021 Abandoned
Menu